TOP STORIES

• REGULATORY May Listing OK’ed for Darzquro, Pemazyre, Vitrakvi, Kesimpta and More
  May 12, 2021

• REGULATORY Ultomiris Faces 4.3% Price Cut under CEA Scheme
  May 12, 2021

• REGULATORY Tecentriq, 3 I/O Rivals Face Quarterly Re-Pricing; Price Cuts Yet Again for Opdivo, Keytruda
  May 11, 2021

• BUSINESS Takeda Submits Positive Japan Data for Approval-Pending Moderna Vaccine
  May 11, 2021

• BUSINESS Novartis Says Only 3,000 Pollen Allergy Patients Used Xolair This Season, Less than 10% of Re-Pricing Line
  May 10, 2021

• ORGANIZATION JPMA Has “Different View” from US Govt on COVID-19 Vaccine IP Waiver
  May 10, 2021

• BUSINESS Kyoto Startup to Begin Clinical Trial of iPSC-Derived Platelet Agent This Year, Eyes 10 Billion Yen Biz
  May 10, 2021

• BUSINESS Drug Makers’ Female Manager Ratio at 12.5%; Major Gap between Japan, Foreign Players
  April 30, 2021

• REGULATORY MHLW Revokes Approval for 12 Kobayashi Kako Products, Imposes Biz Improvement Order
  April 30, 2021

• BUSINESS Takeda, Eisai, Chemiphar Ran Early Retirement Programs over Past Year: Survey
  April 28, 2021

• BUSINESS Boehringer’s Japan Pharma Sales Rise 3.1% in 2020 on Ofev, Jardiance
  April 28, 2021

• BUSINESS Novartis Offering Voluntary Redundancy for 3rd Consecutive Year, Targets Sales & Medical across Therapeutic Areas
  April 27, 2021

• REGULATORY LDP Team Adopts Proposals to Push Japan-Made COVID-19 Vaccines, Urges Approval with Safety/Immunogenicity Studies
  April 27, 2021

• ACADEMIA New RA Guidelines Upgrade Position of JAK Inhibitors, Biosimilars on Equal Footing with Reference Products
  April 26, 2021

• REGULATORY Olumiant Snags Japan Approval for COVID-19
  April 23, 2021

• BUSINESS Chugai Eyes Japan Submission for COVID-19 Antibody Cocktail by Year-End
  April 23, 2021

• BUSINESS Supply Delays Likely for 160 Nichi-Iko Products despite Biz Suspension Lifted
  April 22, 2021

• REGULATORY Olumiant Now in Line for Japan Nod for COVID-19 Pneumonia
  April 22, 2021

• BUSINESS MSD Japan Suffers 7% Sales Dip on Repeated Keytruda Re-Pricing, Urges Policy Rethink
  April 21, 2021

• ORGANIZATION EFPIA Issues Proposals for Japanese CEA System, Says “Cannot Accept” Expansion without Corrective Steps
  April 21, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 94
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• …
• Next ›
• 最終 »